These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 16153628

  • 1. Effect of nandrolone decanonate on paraoxonase activity in hemodialysis patients.
    Ghorbanihaghjo A, Argani H, Rahbaninoubar M, Rashtchizadeh N.
    Clin Biochem; 2005 Dec; 38(12):1076-80. PubMed ID: 16153628
    [Abstract] [Full Text] [Related]

  • 2. Paraoxonase enzyme activity is enhanced by zinc supplementation in hemodialysis patients.
    Rahimi-Ardabili B, Argani H, Ghorbanihaghjo A, Rashtchizadeh N, Naghavi-Behzad M, Ghorashi S, Nezami N.
    Ren Fail; 2012 Dec; 34(9):1123-8. PubMed ID: 22950600
    [Abstract] [Full Text] [Related]

  • 3. [Relation between paraoxonase activity, other HDL components and inflammatory state in hemodialyzed patients].
    González AI, Brites F, Elbert A, Gómez-Rosso L, Berg G, Wikinski R, Schreier L.
    Medicina (B Aires); 2010 Dec; 70(6):508-12. PubMed ID: 21163737
    [Abstract] [Full Text] [Related]

  • 4. Serum paraoxonase activity in uremic predialysis and hemodialysis patients.
    Dirican M, Akca R, Sarandol E, Dilek K.
    J Nephrol; 2004 Dec; 17(6):813-8. PubMed ID: 15593056
    [Abstract] [Full Text] [Related]

  • 5. Acrolein inactivates paraoxonase 1: changes in free acrolein levels after hemodialysis correlate with increases in paraoxonase 1 activity in chronic renal failure patients.
    Gugliucci A, Lunceford N, Kinugasa E, Ogata H, Schulze J, Kimura S.
    Clin Chim Acta; 2007 Sep; 384(1-2):105-12. PubMed ID: 17632094
    [Abstract] [Full Text] [Related]

  • 6. Serum paraoxonase/arylesterase activities in phenylketonuric patients on diet.
    Schulpis KH, Bartzeliotou A, Tsakiris S, Gounaris A, Papassotiriou I.
    Eur J Clin Nutr; 2007 Jun; 61(6):803-8. PubMed ID: 17203019
    [Abstract] [Full Text] [Related]

  • 7. Kinetics of HDL cholesterol and paraoxonase activity in moderate alcohol consumers.
    Sierksma A, van der Gaag MS, van Tol A, James RW, Hendriks HF.
    Alcohol Clin Exp Res; 2002 Sep; 26(9):1430-5. PubMed ID: 12351939
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of rosuvastatin versus atorvastatin treatment on paraoxonase-1 activity in men with established cardiovascular disease and a low HDL-cholesterol.
    Bergheanu SC, Van Tol A, Dallinga-Thie GM, Liem A, Dunselman PH, Van der Bom JG, Jukema JW.
    Curr Med Res Opin; 2007 Sep; 23(9):2235-40. PubMed ID: 17692153
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effect of atorvastatin therapy on lecithin:cholesterol acyltransferase, cholesteryl ester transfer protein and the antioxidant paraoxonase.
    Kassai A, Illyés L, Mirdamadi HZ, Seres I, Kalmár T, Audikovszky M, Paragh G.
    Clin Biochem; 2007 Jan; 40(1-2):1-5. PubMed ID: 16999950
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Apolipoproteins A1 and B levels and serum cholinesterase activity in hyperlipidemic subjects.
    Olinic D, Stoia M, Marian I, Trif I, Cucuianu M.
    Rom J Intern Med; 1999 Jan; 37(1):71-9. PubMed ID: 15523947
    [Abstract] [Full Text] [Related]

  • 17. Oxidation of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in major depressive disorder.
    Sarandol A, Sarandol E, Eker SS, Karaagac EU, Hizli BZ, Dirican M, Kirli S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug 30; 30(6):1103-8. PubMed ID: 16716479
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease.
    Zambon A, Brown BG, Deeb SS, Brunzell JD.
    J Intern Med; 2006 May 30; 259(5):473-80. PubMed ID: 16629853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.